Template:CMV neurologic disease treatment: Difference between revisions
Ostermayer (talk | contribs) (Marked this version for translation) |
(Convert to AntibioticDose with disease=CMV neurologic disease for SMW linking) |
||
| Line 2: | Line 2: | ||
<translate> | <translate> | ||
<!--T:1--> | <!--T:1--> | ||
* | *{{AntibioticDose|disease=CMV neurologic disease|drug=Ganciclovir|dose=5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs|context=Combined with Foscarnet|population=Adult}} + | ||
** | **{{AntibioticDose|disease=CMV neurologic disease|drug=Foscarnet|dose=90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs|context=Combined with Ganciclovir|population=Adult}} | ||
</translate> | </translate> | ||
Revision as of 01:28, 20 March 2026
- Ganciclovir 5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs +
- Foscarnet 90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs